Telehealth for Childhood Asthma
(TEACH-ER Trial)
Trial Summary
What is the purpose of this trial?
The investigators propose a randomized controlled trial of Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER) vs. enhanced care (EC). TEACH-ER includes: 1) brief, pictorial, and health literacy-informed asthma education in the ED, with color- and shape-coded labels provided for home asthma medications; 2) virtual primary care follow-up within 1 week of discharge using in-home telemedicine (Zoom) when possible, featuring provider prompts for guideline-based preventive therapy and home delivery of prescribed medications with pictorial action plans; 3) two additional in-home virtual visits to reinforce teaching, review treatment plans, label medications, and support effective management practices. The investigators will enroll 430 children (ages 3-12 yrs) from the two dedicated pediatric EDs in our region, and follow all participants for a 12-month period. The investigators will call caregivers to complete blinded follow-up telephone surveys at 3, 6, 9, and 12 months after discharge. The investigators will assess the effectiveness of TEACH-ER in reducing the need for additional asthma-related ED visits or hospitalizations in the 1-months after enrollment. Additional outcomes of interest include asthma symptoms, medication adherence, absenteeism from work and school, quality of life, and the delivery of care consistent with national asthma care guidelines.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications. It seems likely that participants will continue their current asthma medications, as the study focuses on enhancing asthma care.
What data supports the effectiveness of the treatment Enhanced Care (EC), Psychoeducational and Supportive Intervention, Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER) for childhood asthma?
Is telehealth for childhood asthma safe for children?
How is the TEACH-ER treatment for childhood asthma unique?
Eligibility Criteria
This trial is for children aged 3-12 with persistent asthma or poor control, living in Monroe County, NY. They must have had an emergency visit for acute asthma and be on a daily controller medication as per NHLBI guidelines. Excluded are those who can't understand English or Spanish, lack phone access, are in foster care without guardian consent, or have other significant medical conditions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Education and Discharge
Brief, pictorial, and health literacy-informed asthma education in the ED, with color- and shape-coded labels provided for home asthma medications
Telehealth Follow-up
Virtual primary care follow-up within 1 week of discharge using in-home telemedicine, featuring provider prompts for guideline-based preventive therapy and home delivery of prescribed medications with pictorial action plans
Continued Virtual Visits
Two additional in-home virtual visits to reinforce teaching, review treatment plans, label medications, and support effective management practices
Follow-up
Participants are monitored for safety and effectiveness after treatment through blinded follow-up telephone surveys at 3, 6, 9, and 12 months after discharge
Treatment Details
Interventions
- Enhanced Care (EC)
- Telehealth-Enhanced Asthma Care for Home After the Emergency Room (TEACH-ER)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Rochester
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator